| [1] |
Ostrom QT, Price M, Neff C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020[J]. Neuro Oncol, 2023, 25(12 Suppl 2): iv1-iv99. DOI: 10.1093/neuonc/noad149.
|
| [2] |
Xie GS, Richard HT. m 6A mRNA modifications in glioblastoma: Emerging prognostic biomarkers and therapeutic targets[J]. Cancers (Basel), 2024, 16(4): 727. DOI: 10.3390/cancers16040727.
|
| [3] |
Huff S, Tiwari SK, Gonzalez GM, et al. m 6A-RNA Demethylase FTO inhibitors impair self-renewal in glioblastoma stem cells[J]. ACS Chem Biol, 2021, 16(2): 324-333. DOI: 10.1021/acschembio.0c00841.
|
| [4] |
|
| [5] |
Li Y, Wu K, Quan W, et al. The dynamics of FTO binding and demethylation from the m6A motifs[J]. RNA Biol, 2019, 16(9): 1179-1189. DOI: 10.1080/15476286.2019.1621120.
|
| [6] |
Gerken T, Girard CA, Tung YC, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase[J]. Science, 2007, 318(5855): 1469-1472. DOI: 10.1126/science.1151710.
|
| [7] |
Zhao C, Liu Y, Ju S, et al. Pan-cancer analysis of the N6-methyladenosine eraser FTO as a potential prognostic and immunological biomarker[J]. Int J Gen Med, 2021, 14: 7411-7422. DOI: 10.2147/IJGM.S331752.
|
| [8] |
Pianka ST, Li T, Prins TJ, et al. D-2-HG inhibits IDH1mut glioma growth via FTO inhibition and resultant m6A hypermethylation[J]. Cancer Res Commun, 2024, 4(3): 876-894. DOI: 10.1158/2767-9764.Crc-23-0271.
|
| [9] |
|
| [10] |
Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications[J]. Nat Rev Mol Cell Biol, 2017, 18(1): 31-42. DOI: 10.1038/nrm.2016.132.
|
| [11] |
Yang T, Li Y, Zhao F, et al. Circular RNA foxo3: a promising cancer-associated biomarker[J]. Front Genet, 2021, 12: 652995. DOI: 10.3389/fgene.2021.652995.
|
| [12] |
Azzam SK, Alsafar H, Sajini AA. FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms[J]. Int J Mol Sci, 2022, 23(7): 3800. DOI: 10.3390/ijms23073800.
|
| [13] |
Zhao Y, You S, Yu YQ, et al. Decreased nuclear expression of fto in human primary hepatocellular carcinoma is associated with poor prognosis[J]. Int J Clin Exp Pathol, 2019, 12(9): 3376-3383.
|
| [14] |
Zhang S, Liao K, Miao Z, et al. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5[J]. Neuro Oncol, 2019, 21(10): 1284-1296. DOI: 10.1093/neuonc/noz128.
|
| [15] |
Tao M, Li X, He L, et al. Decreased RNA m6A methylation enhances the process of the epithelial mesenchymal transition and vasculogenic mimicry in glioblastoma[J]. Am J Cancer Res, 2022, 12(2): 893-906.
|
| [16] |
Cai HQ, Zhang MJ, Cheng ZJ. FKBP10 promotes proliferation of glioma cells via activating AKT-CREB-PCNA axis[J]. J Biomed Sci, 2021, 28(1): 13. DOI: 10.1186/s12929-020-00705-3.
|
| [17] |
Duggan JJ, Petrie RJ. The role of dynamic reciprocity in 3D cell migration: connecting cell and matrix mechanics to migratory plasticity[J]. NPJ Biol Phys Mech, 2025, 2(1): 21. DOI: 10.1038/s44341-025-00027-1.
|
| [18] |
Berges R, Balzeau J, Peterson AC, et al. A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis[J]. Mol Ther, 2012, 20(7): 1367-1377. DOI: 10.1038/mt.2012.45.
|
| [19] |
Tao B, Huang X, Shi J, et al. FTO interacts with FOXO3a to enhance its transcriptional activity and inhibits aggression in gliomas[J]. Signal Transduct Target Ther, 2020, 5(1): 130. DOI: 10.1038/s41392-020-00234-3.
|
| [20] |
Cai X, Feng S, Zhang J, et al. USP18 deubiquitinates and stabilizes Twist1 to promote epithelial-mesenchymal transition in glioblastoma cells[J]. Am J Cancer Res, 2020, 10(4): 1156-1169. DOI: 10.62572/ajcr.2020.10.4.1156.
|
| [21] |
Wu P, Cai J, Chen Q, et al. Lnc-TALC promotes O 6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p[J]. Nat Commun, 2019, 10(1): 2045. DOI: 10.1038/s41467-019-10025-2.
|
| [22] |
Wu R, Zhao B, Ren X, et al. MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway[J]. Cancer Manag Res, 2020, 12: 6241-6249. DOI: 10.2147/CMAR.S255419.
|
| [23] |
Jiang Y, Fan C, Tan Q, et al. Exosomal miR-27a-3p promotes osteosarcoma lung metastasis by negatively regulating TNFAIP3 to form a premetastatic niche[J]. Mol Genet Genomics, 2026, 301(1): 108. DOI: 10.1007/s00438-026-02431-1.
|